Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases

Fierce Pharma ------- Bristol-Myers Squibb and Pfizer are riding a hot streak in court defending against Eliquis liability lawsuits, most recently with a judge’s decision to toss 20 cases in New York. With the ruling and an earlier round of victories, the drugmakers have whittled away all but one lawsuit in a set accusing the company of downplaying the drug's bleeding risks, Pfizer says. A U.S. federal judge for the Southern District of New York threw out 20 cases last week after finding that the med’s labeling information is adequate and that the state law allegations in the suits were preempted by federal law. The plaintiffs had argued that the drugmakers are responsible for their injuries because the anticoagulant was overly dangerous and because the companies failed to warn about bleeding risks. To learn more click on the picture below to read the article.